Trial Profile
Neurophysiological analysis of developmental disorders: an exploratory neuroimaging study using functional near-infrared spectroscopy (fNIRS)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2012
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 05 Jul 2012 New trial record